Leerink Swann maintains an 'Outperform' on Corcept Therapeutics (CORT); Korlym Approved. Launch To Start On May 1
Go back to Leerink Swann maintains an 'Outperform' on Corcept Therapeutics (CORT); Korlym Approved. Launch To Start On May 1| Corcept Therapeutics, Inc. (NASDAQ: CORT) | Delayed: 91.88 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $91.88 | 52 Week High | $10.00 | |||
| Open | $91.88 | 52 Week Low | $3.22 | |||
| Day High | $91.88 | P/E | N/A | |||
| Day Low | $91.88 | EPS | $-0.46 | |||
| Volume | 5 | |||||
